<span item_type="fundamental" item_id="c14bbbc46cd6b5229eaa3f0ff2ece13c" counter_id="ST/US/HSPTU" env="prod"></span><span item_type="announcement" item_id="549380470410780289" env="prod"></span><p>EPS: As of FY2025 Q2, the actual value is USD 0.05.</p><p></p><h3>Segment Revenue</h3><ul><li>The company has not generated any operating revenues as of June 30, 2025, as it is a blank check company focused on identifying and evaluating suitable acquisition transaction candidates.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2032950/000192998025000620/hspt_10q.htm"></span></li></ul><h3>Operational Metrics</h3><ul><li>For the three months ended June 30, 2025, the company reported a net income of $221,282, primarily due to interest and dividend income of $730,448 from investments held in trust, offset by formation and operating expenses of $509,166.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2032950/000192998025000620/hspt_10q.htm"></span></li><li>For the six months ended June 30, 2025, the company reported a net income of $693,874, with interest and dividend income of $1,456,519 offset by formation and operating expenses of $762,645.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2032950/000192998025000620/hspt_10q.htm"></span></li></ul><h3>Cash Flow</h3><ul><li>As of June 30, 2025, the company had cash of $26,030 and a working capital deficit of $311,770.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2032950/000192998025000620/hspt_10q.htm"></span></li><li>Net cash used in operating activities for the six months ended June 30, 2025, was - $620,690.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2032950/000192998025000620/hspt_10q.htm"></span></li></ul><h3>Unique Metrics</h3><ul><li>The company has placed $70,801,049 in a trust account, which includes interest earned on investments held in the trust account.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2032950/000192998025000620/hspt_10q.htm"></span></li></ul><h3>Future Outlook and Strategy</h3><ul><li><strong>Core Business Focus</strong>: The company is focused on completing a business combination with SL Bio Ltd., a Cayman Islands exempted company, which is expected to result in SL Bio becoming a subsidiary of PubCo, with the PubCo Ordinary Shares expected to be listed on the Nasdaq Stock Market LLC.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2032950/000192998025000620/hspt_10q.htm"></span></li><li><strong>Non-Core Business</strong>: The company has not commenced any operations and will not generate operating revenues until after the completion of a business combination.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2032950/000192998025000620/hspt_10q.htm"></span></li><li><strong>Priority</strong>: The company plans to use the proceeds from the IPO and private placement to acquire a target business and finance its operations post-acquisition.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2032950/000192998025000620/hspt_10q.htm"></span></li></ul>

Horizon Space Acquisition Il - Unit | 10-Q: FY2025 Q2 EPS: USD 0.05